▶ 調査レポート

世界の子宮内膜症治療薬市場:専門的調査

• 英文タイトル:Global Endometriosis Treatment Drugs Market Professional Survey Report 2019

QYResearchが調査・発行した産業分析レポートです。世界の子宮内膜症治療薬市場:専門的調査 / Global Endometriosis Treatment Drugs Market Professional Survey Report 2019 / QYR9ST05993資料のイメージです。• レポートコード:QYR9ST05993
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥518,000 (USD3,500)▷ お問い合わせ
  Enterprise License¥1,036,000 (USD7,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※本調査レポートは、子宮内膜症治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口剤、その他に、用途別には、病院薬局、小売薬局、電子商取引、その他にセグメント区分し、子宮内膜症治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・子宮内膜症治療薬の世界市場概要
・子宮内膜症治療薬の製造コスト構成分析
・子宮内膜症治療薬の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・子宮内膜症治療薬の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・子宮内膜症治療薬のセグメント分析(種類別)
(経口剤、その他)
・子宮内膜症治療薬のセグメント分析(用途別)
(病院薬局、小売薬局、電子商取引、その他)
・子宮内膜症治療薬の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(AbbVie Inc、Bayer AG、AstraZeneca、Pfizer Inc、Teva Pharmaceutical Industries Ltd、Ipsen Pharma、Myovant Sciences Ltd、Endoceutics, Inc、Debiopharm Group、Mayne Pharma Group)
・子宮内膜症治療薬の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...

Endometriosis affects a large number of women who are in their reproductive age. It is estimated to have a prevalence rate of 1 in 10 among women in the reproductive age group. The number is rising with the growing population count in that age range. Though there isn’t a complete cure for this condition, effective endometriosis treatment is provided through medication which suppresses the extreme pain suffered during endometriosis. There are many assumptions to be taken in order to estimate the correct prevalence of endometriosis patients. The absolute prevalent population is always limited as most cases in developing regions are not reported. Also, the awareness and understanding of different scales of pain is very limited in most regions. Hence, cases of endometriosis often get ignored. The situation persists in not only developing or poor socio-economic countries, but developed countries like the UK, where it is assumed that around 2 million women have undiagnosed endometriosis.
The global Endometriosis Treatment Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Endometriosis Treatment Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Endometriosis Treatment Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Endometriosis Treatment Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Endometriosis Treatment Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AbbVie Inc
Bayer AG
AstraZeneca
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Ipsen Pharma
Myovant Sciences Ltd
Endoceutics, Inc
Debiopharm Group
Mayne Pharma Group

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Oral Type
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-Commerce
Others

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Endometriosis Treatment Drugs
1.1 Definition of Endometriosis Treatment Drugs
1.2 Endometriosis Treatment Drugs Segment by Type
1.2.1 Global Endometriosis Treatment Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Oral Type
1.2.3 Others
1.3 Endometriosis Treatment Drugs Segment by Applications
1.3.1 Global Endometriosis Treatment Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-Commerce
1.3.5 Others
1.4 Global Endometriosis Treatment Drugs Overall Market
1.4.1 Global Endometriosis Treatment Drugs Revenue (2014-2025)
1.4.2 Global Endometriosis Treatment Drugs Production (2014-2025)
1.4.3 North America Endometriosis Treatment Drugs Status and Prospect (2014-2025)
1.4.4 Europe Endometriosis Treatment Drugs Status and Prospect (2014-2025)
1.4.5 China Endometriosis Treatment Drugs Status and Prospect (2014-2025)
1.4.6 Japan Endometriosis Treatment Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Endometriosis Treatment Drugs Status and Prospect (2014-2025)
1.4.8 India Endometriosis Treatment Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Endometriosis Treatment Drugs
2.3 Manufacturing Process Analysis of Endometriosis Treatment Drugs
2.4 Industry Chain Structure of Endometriosis Treatment Drugs

3 Development and Manufacturing Plants Analysis of Endometriosis Treatment Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Endometriosis Treatment Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Endometriosis Treatment Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Endometriosis Treatment Drugs Production and Capacity Analysis
4.2 Endometriosis Treatment Drugs Revenue Analysis
4.3 Endometriosis Treatment Drugs Price Analysis
4.4 Market Concentration Degree

5 Endometriosis Treatment Drugs Regional Market Analysis
5.1 Endometriosis Treatment Drugs Production by Regions
5.1.1 Global Endometriosis Treatment Drugs Production by Regions
5.1.2 Global Endometriosis Treatment Drugs Revenue by Regions
5.2 Endometriosis Treatment Drugs Consumption by Regions
5.3 North America Endometriosis Treatment Drugs Market Analysis
5.3.1 North America Endometriosis Treatment Drugs Production
5.3.2 North America Endometriosis Treatment Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Endometriosis Treatment Drugs Import and Export
5.4 Europe Endometriosis Treatment Drugs Market Analysis
5.4.1 Europe Endometriosis Treatment Drugs Production
5.4.2 Europe Endometriosis Treatment Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Endometriosis Treatment Drugs Import and Export
5.5 China Endometriosis Treatment Drugs Market Analysis
5.5.1 China Endometriosis Treatment Drugs Production
5.5.2 China Endometriosis Treatment Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Endometriosis Treatment Drugs Import and Export
5.6 Japan Endometriosis Treatment Drugs Market Analysis
5.6.1 Japan Endometriosis Treatment Drugs Production
5.6.2 Japan Endometriosis Treatment Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Endometriosis Treatment Drugs Import and Export
5.7 Southeast Asia Endometriosis Treatment Drugs Market Analysis
5.7.1 Southeast Asia Endometriosis Treatment Drugs Production
5.7.2 Southeast Asia Endometriosis Treatment Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Endometriosis Treatment Drugs Import and Export
5.8 India Endometriosis Treatment Drugs Market Analysis
5.8.1 India Endometriosis Treatment Drugs Production
5.8.2 India Endometriosis Treatment Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Endometriosis Treatment Drugs Import and Export

6 Endometriosis Treatment Drugs Segment Market Analysis (by Type)
6.1 Global Endometriosis Treatment Drugs Production by Type
6.2 Global Endometriosis Treatment Drugs Revenue by Type
6.3 Endometriosis Treatment Drugs Price by Type

7 Endometriosis Treatment Drugs Segment Market Analysis (by Application)
7.1 Global Endometriosis Treatment Drugs Consumption by Application
7.2 Global Endometriosis Treatment Drugs Consumption Market Share by Application (2014-2019)

8 Endometriosis Treatment Drugs Major Manufacturers Analysis
8.1 AbbVie Inc
8.1.1 AbbVie Inc Endometriosis Treatment Drugs Production Sites and Area Served
8.1.2 AbbVie Inc Product Introduction, Application and Specification
8.1.3 AbbVie Inc Endometriosis Treatment Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bayer AG
8.2.1 Bayer AG Endometriosis Treatment Drugs Production Sites and Area Served
8.2.2 Bayer AG Product Introduction, Application and Specification
8.2.3 Bayer AG Endometriosis Treatment Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 AstraZeneca
8.3.1 AstraZeneca Endometriosis Treatment Drugs Production Sites and Area Served
8.3.2 AstraZeneca Product Introduction, Application and Specification
8.3.3 AstraZeneca Endometriosis Treatment Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Pfizer Inc
8.4.1 Pfizer Inc Endometriosis Treatment Drugs Production Sites and Area Served
8.4.2 Pfizer Inc Product Introduction, Application and Specification
8.4.3 Pfizer Inc Endometriosis Treatment Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Teva Pharmaceutical Industries Ltd
8.5.1 Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Production Sites and Area Served
8.5.2 Teva Pharmaceutical Industries Ltd Product Introduction, Application and Specification
8.5.3 Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Ipsen Pharma
8.6.1 Ipsen Pharma Endometriosis Treatment Drugs Production Sites and Area Served
8.6.2 Ipsen Pharma Product Introduction, Application and Specification
8.6.3 Ipsen Pharma Endometriosis Treatment Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Myovant Sciences Ltd
8.7.1 Myovant Sciences Ltd Endometriosis Treatment Drugs Production Sites and Area Served
8.7.2 Myovant Sciences Ltd Product Introduction, Application and Specification
8.7.3 Myovant Sciences Ltd Endometriosis Treatment Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Endoceutics, Inc
8.8.1 Endoceutics, Inc Endometriosis Treatment Drugs Production Sites and Area Served
8.8.2 Endoceutics, Inc Product Introduction, Application and Specification
8.8.3 Endoceutics, Inc Endometriosis Treatment Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Debiopharm Group
8.9.1 Debiopharm Group Endometriosis Treatment Drugs Production Sites and Area Served
8.9.2 Debiopharm Group Product Introduction, Application and Specification
8.9.3 Debiopharm Group Endometriosis Treatment Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Mayne Pharma Group
8.10.1 Mayne Pharma Group Endometriosis Treatment Drugs Production Sites and Area Served
8.10.2 Mayne Pharma Group Product Introduction, Application and Specification
8.10.3 Mayne Pharma Group Endometriosis Treatment Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Endometriosis Treatment Drugs Market
9.1 Global Endometriosis Treatment Drugs Market Trend Analysis
9.1.1 Global Endometriosis Treatment Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Endometriosis Treatment Drugs Regional Market Trend
9.2.1 North America Endometriosis Treatment Drugs Forecast 2019-2025
9.2.2 Europe Endometriosis Treatment Drugs Forecast 2019-2025
9.2.3 China Endometriosis Treatment Drugs Forecast 2019-2025
9.2.4 Japan Endometriosis Treatment Drugs Forecast 2019-2025
9.2.5 Southeast Asia Endometriosis Treatment Drugs Forecast 2019-2025
9.2.6 India Endometriosis Treatment Drugs Forecast 2019-2025
9.3 Endometriosis Treatment Drugs Market Trend (Product Type)
9.4 Endometriosis Treatment Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Endometriosis Treatment Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Endometriosis Treatment Drugs
Table Global Endometriosis Treatment Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Endometriosis Treatment Drugs Production Market Share by Types in 2018
Figure Oral Type Product Picture
Figure Others Product Picture
Table Global Endometriosis Treatment Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Endometriosis Treatment Drugs Consumption Market Share by Applications in 2018
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure E-Commerce
Figure Others
Figure Global Endometriosis Treatment Drugs Revenue (Million USD) (2014-2025)
Figure Global Endometriosis Treatment Drugs Production (K Units) (2014-2025)
Figure North America Endometriosis Treatment Drugs Market Size (Million USD) (2014-2025)
Figure Europe Endometriosis Treatment Drugs Market Size (Million USD) (2014-2025)
Figure China Endometriosis Treatment Drugs Market Size (Million USD) (2014-2025)
Figure Japan Endometriosis Treatment Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Endometriosis Treatment Drugs Market Size (Million USD) (2014-2025)
Figure India Endometriosis Treatment Drugs Market Size (Million USD) (2014-2025)
Table Endometriosis Treatment Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Endometriosis Treatment Drugs in 2018
Figure Manufacturing Process Analysis of Endometriosis Treatment Drugs
Figure Industry Chain Structure of Endometriosis Treatment Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Endometriosis Treatment Drugs Manufacturing Plants Distribution
Table Endometriosis Treatment Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Endometriosis Treatment Drugs Capacity (K Units) of Major Manufacturers (2014-2019)
Table Endometriosis Treatment Drugs Production (K Units) of Major Manufacturers (2014-2019)
Table Endometriosis Treatment Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Endometriosis Treatment Drugs Production Share by Manufacturers in 2018
Table Endometriosis Treatment Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Endometriosis Treatment Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Endometriosis Treatment Drugs Revenue Share by Manufacturers in 2018
Table Endometriosis Treatment Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Endometriosis Treatment Drugs Production by Regions 2014-2019 (K Units)
Table Global Endometriosis Treatment Drugs Production Market Share by Regions 2014-2019
Figure Global Endometriosis Treatment Drugs Production Market Share by Regions in 2018
Table Global Endometriosis Treatment Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Endometriosis Treatment Drugs Revenue Market Share by Regions 2014-2019
Figure Global Endometriosis Treatment Drugs Revenue Market Share by Regions in 2018
Table Global Endometriosis Treatment Drugs Consumption by Regions 2014-2019 (K Units)
Table Global Endometriosis Treatment Drugs Consumption Market Share by Regions 2014-2019
Figure North America Endometriosis Treatment Drugs Production Growth Rate 2014-2019 (K Units)
Figure North America Endometriosis Treatment Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Endometriosis Treatment Drugs Production, Consumption Import and Export (K Units)
Figure Europe Endometriosis Treatment Drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe Endometriosis Treatment Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Endometriosis Treatment Drugs Production, Consumption Import and Export (K Units)
Figure China Endometriosis Treatment Drugs Production Growth Rate 2014-2019 (K Units)
Figure China Endometriosis Treatment Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Endometriosis Treatment Drugs Production, Consumption Import and Export (K Units)
Figure Japan Endometriosis Treatment Drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan Endometriosis Treatment Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Endometriosis Treatment Drugs Production, Consumption Import and Export (K Units)
Figure Southeast Asia Endometriosis Treatment Drugs Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Endometriosis Treatment Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Endometriosis Treatment Drugs Production, Consumption Import and Export (K Units)
Figure India Endometriosis Treatment Drugs Production Growth Rate 2014-2019 (K Units)
Figure India Endometriosis Treatment Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Endometriosis Treatment Drugs Production, Consumption Import and Export (K Units)
Figure Global Consumption Endometriosis Treatment Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Endometriosis Treatment Drugs Market Share by Application (2014-2019)
Table AbbVie Inc Endometriosis Treatment Drugs Production Sites and Area Served
Table AbbVie Inc Endometriosis Treatment Drugs Product Introduction, Application and Specification
Table AbbVie Inc Endometriosis Treatment Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Inc Endometriosis Treatment Drugs Production Growth Rate (2014-2019)
Table AbbVie Inc Endometriosis Treatment Drugs Production Market Share (2014-2019)
Figure AbbVie Inc Endometriosis Treatment Drugs Revenue Market Share (2014-2019)
Table AbbVie Inc Endometriosis Treatment Drugs Main Business and Markets Served
Table Bayer AG Endometriosis Treatment Drugs Production Sites and Area Served
Table Bayer AG Endometriosis Treatment Drugs Product Introduction, Application and Specification
Table Bayer AG Endometriosis Treatment Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer AG Endometriosis Treatment Drugs Production Growth Rate (2014-2019)
Table Bayer AG Endometriosis Treatment Drugs Production Market Share (2014-2019)
Figure Bayer AG Endometriosis Treatment Drugs Revenue Market Share (2014-2019)
Table Bayer AG Endometriosis Treatment Drugs Main Business and Markets Served
Table AstraZeneca Endometriosis Treatment Drugs Production Sites and Area Served
Table AstraZeneca Endometriosis Treatment Drugs Product Introduction, Application and Specification
Table AstraZeneca Endometriosis Treatment Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Endometriosis Treatment Drugs Production Growth Rate (2014-2019)
Table AstraZeneca Endometriosis Treatment Drugs Production Market Share (2014-2019)
Figure AstraZeneca Endometriosis Treatment Drugs Revenue Market Share (2014-2019)
Table AstraZeneca Endometriosis Treatment Drugs Main Business and Markets Served
Table Pfizer Inc Endometriosis Treatment Drugs Production Sites and Area Served
Table Pfizer Inc Endometriosis Treatment Drugs Product Introduction, Application and Specification
Table Pfizer Inc Endometriosis Treatment Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Inc Endometriosis Treatment Drugs Production Growth Rate (2014-2019)
Table Pfizer Inc Endometriosis Treatment Drugs Production Market Share (2014-2019)
Figure Pfizer Inc Endometriosis Treatment Drugs Revenue Market Share (2014-2019)
Table Pfizer Inc Endometriosis Treatment Drugs Main Business and Markets Served
Table Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Production Sites and Area Served
Table Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Product Introduction, Application and Specification
Table Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Production Growth Rate (2014-2019)
Table Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Production Market Share (2014-2019)
Figure Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Main Business and Markets Served
Table Ipsen Pharma Endometriosis Treatment Drugs Production Sites and Area Served
Table Ipsen Pharma Endometriosis Treatment Drugs Product Introduction, Application and Specification
Table Ipsen Pharma Endometriosis Treatment Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Ipsen Pharma Endometriosis Treatment Drugs Production Growth Rate (2014-2019)
Table Ipsen Pharma Endometriosis Treatment Drugs Production Market Share (2014-2019)
Figure Ipsen Pharma Endometriosis Treatment Drugs Revenue Market Share (2014-2019)
Table Ipsen Pharma Endometriosis Treatment Drugs Main Business and Markets Served
Table Myovant Sciences Ltd Endometriosis Treatment Drugs Production Sites and Area Served
Table Myovant Sciences Ltd Endometriosis Treatment Drugs Product Introduction, Application and Specification
Table Myovant Sciences Ltd Endometriosis Treatment Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Myovant Sciences Ltd Endometriosis Treatment Drugs Production Growth Rate (2014-2019)
Table Myovant Sciences Ltd Endometriosis Treatment Drugs Production Market Share (2014-2019)
Figure Myovant Sciences Ltd Endometriosis Treatment Drugs Revenue Market Share (2014-2019)
Table Myovant Sciences Ltd Endometriosis Treatment Drugs Main Business and Markets Served
Table Endoceutics, Inc Endometriosis Treatment Drugs Production Sites and Area Served
Table Endoceutics, Inc Endometriosis Treatment Drugs Product Introduction, Application and Specification
Table Endoceutics, Inc Endometriosis Treatment Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Endoceutics, Inc Endometriosis Treatment Drugs Production Growth Rate (2014-2019)
Table Endoceutics, Inc Endometriosis Treatment Drugs Production Market Share (2014-2019)
Figure Endoceutics, Inc Endometriosis Treatment Drugs Revenue Market Share (2014-2019)
Table Endoceutics, Inc Endometriosis Treatment Drugs Main Business and Markets Served
Table Debiopharm Group Endometriosis Treatment Drugs Production Sites and Area Served
Table Debiopharm Group Endometriosis Treatment Drugs Product Introduction, Application and Specification
Table Debiopharm Group Endometriosis Treatment Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Debiopharm Group Endometriosis Treatment Drugs Production Growth Rate (2014-2019)
Table Debiopharm Group Endometriosis Treatment Drugs Production Market Share (2014-2019)
Figure Debiopharm Group Endometriosis Treatment Drugs Revenue Market Share (2014-2019)
Table Debiopharm Group Endometriosis Treatment Drugs Main Business and Markets Served
Table Mayne Pharma Group Endometriosis Treatment Drugs Production Sites and Area Served
Table Mayne Pharma Group Endometriosis Treatment Drugs Product Introduction, Application and Specification
Table Mayne Pharma Group Endometriosis Treatment Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Mayne Pharma Group Endometriosis Treatment Drugs Production Growth Rate (2014-2019)
Table Mayne Pharma Group Endometriosis Treatment Drugs Production Market Share (2014-2019)
Figure Mayne Pharma Group Endometriosis Treatment Drugs Revenue Market Share (2014-2019)
Table Mayne Pharma Group Endometriosis Treatment Drugs Main Business and Markets Served
Figure Global Endometriosis Treatment Drugs Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Endometriosis Treatment Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Endometriosis Treatment Drugs Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Endometriosis Treatment Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Endometriosis Treatment Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Endometriosis Treatment Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Endometriosis Treatment Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Endometriosis Treatment Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Endometriosis Treatment Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Endometriosis Treatment Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Endometriosis Treatment Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Endometriosis Treatment Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Endometriosis Treatment Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Endometriosis Treatment Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Endometriosis Treatment Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Endometriosis Treatment Drugs by Type (2019-2025)
Table Global Consumption (K Units) of Endometriosis Treatment Drugs by Application (2019-2025)
Table Endometriosis Treatment Drugs Distributors List
Table Endometriosis Treatment Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources